Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
The Journal of Infectious Diseases|July 25, 2022
Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 InfectionHans P Verkerke, Gregory L Damhorst, Daniel S Graciaa, et al.Medrxiv : the Preprint Server for Health Sciences|February 8, 2022
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimersNarayanaiah Cheedarla, Hans P Verkerke, Sindhu Potlapalli, et al.Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.Journal of Medical Virology|February 8, 2024
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal studySivaprakasam T Selvavinayagam, Suvaiyarasan Suvaithenamudhan, Yean K Yong, et al.Nature Communications|June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lungNanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.Research Square|February 23, 2022
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimersNarayanaiah Cheedarla, Hans P Verkerke, Sindhu Potlapalli, et al.Iscience|November 15, 2023
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimersNarayanaiah Cheedarla, Hans P Verkerke, Sindhu Potlapalli, et al.Structure (London, England : 1993)|May 11, 2023
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody responseAnamika Patel, Sanjeev Kumar, Lilin Lai, et al.Biorxiv : the Preprint Server for Biology|November 3, 2022
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody responseAnamika Patel, Sanjeev Kumar, Lilin Lai, et al.Blood Cancer Discovery|December 13, 2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough InfectionsMaryam I Azeem, Ajay K Nooka, Uma Shanmugasundaram, et al.Pageof 4